VS
Vijay Sing Bhandari
About Vijay Sing Bhandari
Data last updated:
Vijay Sing Bhandari is a Director at Axa Parenterals Limited (since 2022) and Director at Heilsa Life Sciences Private Limited (since 2022). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹232 Cr; the largest is Axa Parenterals Limited at ₹231 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Axa Parenterals Limited U24232DL2005PLC148247 | Director | 16 Mar 2022 | 2005 | ₹231 Cr (FY 2025) | Active |
| Heilsa Life Sciences Private Limited U24100DL2021PTC387167 | Director | 16 Mar 2022 | 2021 | ₹29.8 Lakh (FY 2025) | Active |
Board colleagues of Vijay Sing Bhandari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Puneet Kansal | 00365652 | Axa Parenterals Limited , Heilsa Life Sciences Private Limited | Director |
| Ruchir Gupta | 03257188 | Axa Parenterals Limited , Heilsa Life Sciences Private Limited | Whole-Time Director |
| Sumit Kumar Agarwal | 00445352 | Axa Parenterals Limited , Heilsa Life Sciences Private Limited | Whole-Time Director |
| Sunil Kumar Agarwal | 08347170 | Axa Parenterals Limited | Director |
| Vikas Khanna | 08516309 | Axa Parenterals Limited | Director |
| Yasha Agarwal | 09844717 | Axa Parenterals Limited , Heilsa Life Sciences Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vijay Sing Bhandari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vijay Sing Bhandari
Vijay Sing Bhandari currently holds 2 directorships: Axa Parenterals Limited (Director, since 16 Mar 2022, revenue ₹231 Cr (FY 2025)); Heilsa Life Sciences Private Limited (Director, since 16 Mar 2022, revenue ₹29.8 Lakh (FY 2025)).
Vijay Sing Bhandari was first appointed on 16 Mar 2022 as Director at Axa Parenterals Limited.
The 2 current companies of Vijay Sing Bhandari that report revenue have a combined latest revenue of ₹232 Cr: Axa Parenterals Limited ₹231 Cr (FY 2025); Heilsa Life Sciences Private Limited ₹29.8 Lakh (FY 2025).
The current boards of Vijay Sing Bhandari's companies include Puneet Kansal (Axa Parenterals Limited), Ruchir Gupta (Axa Parenterals Limited), Sumit Kumar Agarwal (Axa Parenterals Limited), Sunil Kumar Agarwal (Axa Parenterals Limited), Vikas Khanna (Axa Parenterals Limited), Yasha Agarwal (Axa Parenterals Limited).